YOUNGBLOOD DR KNEELAND 4

What Happened
Dr. Kneeland Youngblood, a director of Light & Wonder, had 2,391 restricted stock units (RSUs) convert/vest on June 10, 2026 (reported as derivative exercise/conversion) and those 2,391 derivative shares were recorded as disposed on the same date. On the same day she was also granted/awarded 2,498 restricted stock units. The Form 4 shows $0.00 per-share for the conversion/disposition and the award (conversion entries commonly show $0 on these reports); no dollar sale proceeds are reported in the provided filing details.

Key Details

• Transaction date(s): June 10, 2026; Form 4 filed June 12, 2026 (timely filing).
• Transactions reported: conversion/vesting of 2,391 RSUs (code M: exercise/conversion) and simultaneous disposition of those 2,391 derivative shares (code M); grant/award of 2,498 RSUs (code A).
• Reported price/value: $0.00 per share on the Form 4 entries (typical for RSU conversions on these forms); no cash amount for proceeds shown in the provided data.
• Shares owned after the transactions: not specified in the details you provided.
• Footnotes of note:
  • F1: Shares are held via CHESS Depositary Interests (CDIs) on the ASX; each CDI equals one share of common stock.
  • F2: The 2,391 conversion reflects vesting of RSUs granted June 10, 2025; each unit converted one-for-one into common stock.
  • F3: The 2,498 RSUs awarded are scheduled to vest on the earlier of the issuer's 2027 annual meeting or June 10, 2027; each unit converts one-for-one into common stock.

Context

• The filing shows RSU vesting/conversion and an immediate disposition of those converted units; this pattern is common for RSU settlements (e.g., to cover tax withholding or to monetize shares), but the form itself does not state a reason.
• The 2,498-unit award is a time-based RSU grant that has not yet vested and will convert to shares if/when the vesting condition is met.
• These entries relate to equity awards and conversions rather than open-market purchases or sales by the insider for investment signaling purposes; interpret acquisitions (awards) and dispositions (sales) differently when assessing insider activity.